Nalaganje...
A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals
Ebola virus (EBOV) causes a severe hemorrhagic fever with case fatality rates of up to 90%, for which no antiviral therapies are available. Antiviral screening is hampered by the fact that development of cytopathic effect, the easiest means to detect infection with wild-type EBOV, is relatively slow...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787978/ https://ncbi.nlm.nih.gov/pubmed/23751367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2013.05.017 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|